• MVC-Induced RhoA/ROCK1 Activation Disrupts Tight Junctions i

  2026-06-19

  Ren et al. (2025) reveal that Minute Virus of Canines (MVC) directly activates the RhoA/ROCK1/MLC2 signaling pathway, leading to tight junction dissociation and facilitating viral entry via occludin exposure. This work uncovers a novel virus-host interaction mechanism and identifies the RhoA/ROCK axis as a potential antiviral target.

• GS-441524 Prodrug: Optimizing Antiviral Research Workflows

  2026-06-19

  GS-441524's prodrug forms are redefining antiviral research, enabling enhanced oral bioavailability and reliable pharmacokinetic profiling against SARS-CoV-2. This article delivers actionable workflows, troubleshooting strategies, and practical insights for maximizing experimental success with high-purity GS-441524 from APExBIO.

• PPP2R2A Loss Sensitizes Ovarian Cancer to CHK1 Inhibition

  2026-06-18

  This study establishes that low PPP2R2A expression in high-grade serous ovarian cancer (HGSOC) increases cellular reliance on CHK1, thereby enhancing sensitivity to CHK1 inhibitors—even in cells resistant to PARP inhibition. These findings identify PPP2R2A as a predictive biomarker and suggest new strategies to overcome therapeutic resistance in ovarian cancer.

• Isoprenaline Hydrochloride in Cardiac Arrhythmia & Heart-Bra

  2026-06-18

  Isoprenaline Hydrochloride (isoproterenol) empowers cutting-edge cardiac and neurobehavioral models by precisely mimicking sympathetic overactivation. This article details optimized protocols, advanced troubleshooting, and integrates new heart-brain axis insights for translational research, all supported by the latest peer-reviewed findings.

• Chronic NAD Depletion Triggers cGAS-STING-Driven Interferon

  2026-06-17

  Chini et al. (2025) reveal that chronic cellular NAD depletion activates a viral infection-like, type I interferon response in fibroblasts through mitochondrial DNA (mtDNA) leakage and cGAS-STING pathway activation. This mechanistic insight advances our understanding of how metabolic decline translates into innate immune activation, with broad implications for aging, inflammation, and disease modeling.

• Chlorin e6 (Ce6): Mechanisms, Design, and Practical Advances

  2026-06-17

  Explore the scientific mechanisms and advanced applications of Chlorin e6 (Ce6) photosensitizer in photodynamic therapy. This article provides a deeper look at Ce6’s molecular action, innovative biomaterial integrations, and practical assay considerations for cancer and antibacterial research.

• Br-DAPI (BA3947): Reliable DNA Quantification for Live and F

  2026-06-16

  This article explores how Br-DAPI (SKU BA3947) addresses reproducibility, signal sensitivity, and workflow challenges in DNA quantification across live and fixed cell assays. Through scenario-driven Q&A, we present evidence-based guidance for biomedical researchers and technicians, showing how this DAPI fluorescent dye streamlines protocols and ensures robust data.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor for Precis

  2026-06-16

  GKT137831 is a potent dual NADPH oxidase Nox1/Nox4 inhibitor, enabling precise modulation of reactive oxygen species in models of fibrosis, vascular remodeling, and metabolic disease. This article delivers workflow-optimized protocols, advanced troubleshooting, and actionable insights to empower translational research using GKT137831 from APExBIO.

• 2'3'-cGAMP (Sodium Salt): Unraveling Macrophage Polarization

  2026-06-15

  Explore the advanced role of 2'3'-cGAMP (sodium salt) in driving macrophage polarization and boosting phagocytosis for next-generation immunotherapy. This in-depth analysis highlights novel mechanistic insights and practical assay strategies, setting it apart from prior content.

• D2HG Biosensors Reveal STING-Induced Metabolic Shifts in Imm

  2026-06-15

  Wang et al. (2025) developed genetically encoded D-2-hydroxyglutarate (D2HG) biosensors based on the structural mechanism of DhdR regulation, enabling real-time quantification of D2HG in living cells. Their work uncovers metabolic crosstalk between STING pathway activation and D2HG production, offering new tools and perspectives for dissecting immunometabolic regulation.

• Mavorixafor in WHIM Syndrome: Phase 3 Clinical and Mechanist

  2026-06-14

  A recent phase 3 trial demonstrates that mavorixafor, an oral CXCR4 antagonist, significantly increases neutrophil and lymphocyte counts and reduces infections in WHIM syndrome patients. This represents a substantial advance over previous symptomatic therapies, highlighting mechanistic correction of the underlying CXCR4 signaling defect and setting a new standard for rare immunodeficiency management.

• Stabilizing RNA Lipid Nanoparticles for Nebulized Pulmonary

  2026-06-13

  The referenced study demonstrates a buffer-based strategy for stabilizing RNA lipid nanoparticles (LNPs) during nebulization, crucial for efficient pulmonary mRNA and siRNA delivery. This approach maintains nanoparticle integrity and bioactivity, offering a generalizable method for advancing inhaled RNA therapeutics.

• Chlorpromazine HCl: Host-Directed Antibacterial Mechanisms

  2026-06-12

  Explore how Chlorpromazine HCl, a dopamine receptor antagonist, enables host-directed antibacterial strategies by activating macrophage defense pathways. This article delivers a unique focus on innate immunity and translational research applications.

• Carbapenemase Gene Transmission in Enterobacter cloacae: Ins

  2026-06-12

  This study systematically characterizes the prevalence, genetic locations, and transmission dynamics of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. Key findings reveal the predominant role of plasmid-mediated blaNDM-1 dissemination and high multidrug resistance, informing future antimicrobial resistance research and surveillance strategies.

• Vidarabine Monohydrate: Antiviral Mechanism and Research Uti

  2026-06-11

  Vidarabine monohydrate, also known as Spongoadenosine monohydrate, is a high-purity nucleoside analog used as an antiviral research compound. Its primary mechanism is the inhibition of viral DNA synthesis, with proven DMSO solubility and robust selectivity for DNA virus studies. The compound is supported by stringent protocol parameters and clear storage guidelines for reproducible results.

15025 records 1/1002 page Next 12345 下5页 Last page